The effect of intracoronary infusion of bone marrow‐derived mononuclear cells on all‐cause mortality in acute myocardial infarction: rationale and design of the BAMI trial

Over the past 13 years bone marrow‐derived mononuclear cells (BM‐MNCs) have been widely investigated for clinical efficacy in patients following acute myocardial infarction (AMI). These early phase II trials have used various surrogate markers to judge efficacy and, although promising, the results h...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Heart Fail
Autori principali: Mathur, Anthony, Arnold, Roman, Assmus, Birgit, Bartunek, Jozef, Belmans, Ann, Bönig, Halvard, Crea, Filippo, Dimmeler, Stefanie, Dowlut, Sheik, Fernández‐Avilés, Francisco, Galiñanes, Manuel, Garcia‐Dorado, David, Hartikainen, Juha, Hill, Jonathan, Hogardt‐Noll, Annette, Homsy, Christian, Janssens, Stefan, Kala, Petr, Kastrup, Jens, Martin, John, Menasche, Philippe, Miklik, Roman, Mozid, Abdul, San Román, J. Alberto, Sanz‐Ruiz, Ricardo, Tendera, Michal, Wojakowski, Wojtek, Ylä‐Herttuala, Seppo, Zeiher, Andreas
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2017
Soggetti:
New Treatments
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607485/
https://ncbi.nlm.nih.gov/pubmed/28948706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.829
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi